ESPEN guidelines on chronic intestinal failure in adults.

@article{Pironi2016ESPENGO,
  title={ESPEN guidelines on chronic intestinal failure in adults.},
  author={L. Pironi and J. Arends and F. Bozzetti and C. Cuerda and L. Gillanders and P. Jeppesen and F. Joly and D. Kelly and S. Lal and M. Staun and Kinga Szczepanek and A. van Gossum and G. Wanten and S. Schneider},
  journal={Clinical nutrition},
  year={2016},
  volume={35 2},
  pages={
          247-307
        }
}
BACKGROUND & AIMS Chronic Intestinal Failure (CIF) is the long-lasting reduction of gut function, below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth. CIF is the rarest organ failure. Home parenteral nutrition (HPN) is the primary treatment for CIF. No guidelines (GLs) have been developed that address the global management of CIF. These GLs have been devised to generate… Expand
Intestinal failure in adults: Recommendations from the ESPEN expert groups.
TLDR
Much remains to be investigated to improve the diagnosis and management of IF and future studies should rely on multidisciplinary, multicentre and multinational collaborations that gather data from large cohorts of patients. Expand
Emerging treatments for short bowel syndrome in adult patients
TLDR
Clinical studies showed teduglutide to increase urine production and reduce the need for parenteral support volume in patients with SBS with chronic IF, underline the importance of patient monitoring at home and the complexity for HPN adaptation. Expand
Definitions of intestinal failure and the short bowel syndrome.
  • L. Pironi
  • Medicine
  • Best practice & research. Clinical gastroenterology
  • 2016
TLDR
The aspects of the pathophysiology and on the complications of SBS are focused on, which are most relevant in the clinical practice, such as intestinal failure associated liver disease, renal failure, biliary and renal stones, dehydration and electrolyte depletion, magnesium deficiency and D-lactic acidosis. Expand
Teduglutide for treatment of adult patients with short bowel syndrome
TLDR
Teduglutide, an analog of glucagon-like peptide 2, improves intestinal rehabilitation by promoting mucosal growth, reducing intestinal loss and promoting intestinal absorption, and may provide a new treatment strategy for SBS patients with chronic IF. Expand
Parenteral Nutrition and Intestinal Failure
TLDR
Home PN (HPN) is the mainstay of treatment for severe SBS and involves chronic administration of macronutrients, micronutrient, fluid, and electrolytes via central venous access in the patient's home, and requires careful clinical and biochemical monitoring. Expand
Chronic intestinal failure and short bowel syndrome in Crohn’s disease
TLDR
Current literature on CIF and short bowel syndrome is summarized, encompassing epidemiology, pathophysiology, and advances in surgical and medical management, and improvements in the understanding and therapy of CIF-related complications such as catheter-related bloodstream infections and intestinal failure-associated liver disease are elucidated. Expand
[Home parenteral nutrition: a consensus document of experts from Andalucia and Extremadura].
TLDR
The position is defined with regard to the current use of HPN in this country and several controversial questions related to this treatment are answered. Expand
Enteral and Parenteral Nutrition: Considerations for Visceral Transplant Patients
TLDR
The ultimate goal of MV/I transplantation is to optimize a patient’s QOL by establishing full nutritional autonomy, with a full wean from PN and transition to enteral nutrition (EN) and oral diet. Expand
Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
  • L. Pironi
  • Medicine
  • JPEN. Journal of parenteral and enteral nutrition
  • 2019
TLDR
Findings from recent studies that fill some gaps identified in the 2016 ESPEN guidelines regarding the use of teduglutide in the management of SBS-CIF are summarized. Expand
Intestinal failure : a review [ version 1 ; peer review : 2 approved ]
Intestinal failure (IF) is the inability of the gut to absorb necessary water, macronutrients (carbohydrate, protein, and fat), micronutrients, and electrolytes sufficient to sustain life andExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 638 REFERENCES
Short bowel syndrome: clinical guidelines for nutrition management.
TLDR
Small bowel and multivisceral transplantation has evolved during the last decade to be a valid therapeutic option for those patients who cannot be rehabilitated or who fail HPN. Expand
Long-Term Outcome of Chronic Intestinal Pseudo-Obstruction Adult Patients Requiring Home Parenteral Nutrition
TLDR
In this large cohort of CIPO adult patients with severe intestinal failure, i.e., those requiring HPN, a higher survival probability is found than previously reported and should be taken into account when considering intestinal transplantation. Expand
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.
TLDR
This project developed a formal definition and classification of IF, which will facilitate communication and cooperation among professionals in clinical practice, organization and management, and research. Expand
Managing adult patients who need home parenteral nutrition
TLDR
An overview of the indications for and delivery of home parenteral nutrition is provided and advances that promise to limit complications and improve treatment outcomes are discussed. Expand
ESPEN Guidelines on Parenteral Nutrition: gastroenterology.
TLDR
Parenteral nutrition is mandatory in case of intestinal failure, at least in the acute period, and the use of growth hormone, glutamine and GLP-2 cannot be recommended in patients with short bowel. Expand
The Impact of Intestinal Failure on Oral Drug Absorption: A Review
  • Nicola Ward
  • Medicine
  • Journal of Gastrointestinal Surgery
  • 2009
TLDR
The input of specialist pharmacists is necessary in the management of intestinal failure patients to ensure that appropriate drugs and formulations are prescribed in a timely manner to optimize absorption and resultant efficacy. Expand
ESPEN Guidelines on Enteral Nutrition: Gastroenterology.
TLDR
In patients with SBS TF should be introduced in the adaptation phase and should be changed with progressing adaptation to ONS in addition to normal food, and in remission ONS is recommended only in steroid dependent patients in CD. Expand
Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN.
TLDR
HPN is a safe treatment with a high probability of survival and the risk of death during HPN is increased by the absence of a specialist team, and appears greater during the early period of treatment. Expand
Guidelines for management of home parenteral support in adult chronic intestinal failure patients.
TLDR
Education of patients to ensure they self manage home parenteral nutrition (HPN) is cornerstone to obtain minimal rate of technical complications and improvement in quality of life. Expand
Collaborative Strategies to Reduce Mortality and Morbidity in Patients With Chronic Intestinal Failure Including Those Who Are Referred for Small Bowel Transplantation
TLDR
A key recommendation of this group is to establish national intestinal failure databases that can support multicenter studies and lead to the adoption of universally accepted standards of patient care with the goal of improving outcomes in all long-term intestinal failure patients including those requiring intestinal transplantation. Expand
...
1
2
3
4
5
...